PPATP2

Across TCGA pan-cancer cohorts, PPATP2 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated PPATP2 data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher PPATP2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PPATP2 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LAML, OV, and GBM are the cancer types where PPATP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Median	All	0.689	0.441	<.001	42	view →
OV	OS	Tertile	IV	0.076	0.759	.014	36	view →
GBM	DFS	Tertile	All	0.042	0.258	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PPATP2–LAML (DFS)

Open the LAML breakdown →